Indeed, topical application of maresin-1 showed anti-inflammatory effects in an imiquimod-induced psoriasis mouse model by inhibiting the production of IL-17A by γδTCR mid+ and CD4+ cells in the skin through repression in IL-23 receptor expression. Here, IL23R is linked to psoriasis.